Clinical Trial Update: A Study To Assess The Pharmacokinetics Of SB-742457 Formulated As A Capsule And A Tablet In Healthy Elderly Volunteers. [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study comparing SB-742457 capsule and tablet formulations in healthy elderly volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• SB-742457

Snippet

Sponsor: GlaxoSmithKline | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED